Hizentra is an Ig* therapy that provides proven CIDP relapse prevention with the convenience of self-administration, so you can focus on everyday living
Other Ig treatments for chronic inflammatory demyelinating polyneuropathy (CIDP) require IV infusions into your veins. With Hizentra, IV access is not involved: instead you can self-infuse just under the skin, not into a vein, after receiving training from your doctor.
Hizentra gives you proven control with a smaller volume per dose than IVIg, plus convenient dosing to fit your lifestyle. In clinical trials, Hizentra had fewer systemic side effects per infusion (like headache and nausea) than IVIg. The most common side effects in the clinical trials for Hizentra include redness, swelling, itching, and/or bruising at the infusion site; headache; chest, joint or back pain; diarrhea; tiredness; cough; rash; itching; fever, nausea, and vomiting.
Hizentra is a prescription medicine used to treat CIDP in adults.
Subcutaneous Ig is strongly recommended by EAN/PNS* medical guideline for CIDP maintenance
* The European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) are two independent, international organizations of scientists, physicians, and other healthcare providers working together to investigate and treat neurological conditions and promote excellence leading to better care and outcomes.
These programs feature a presentation from a trained nurse and stories from a patient just like you.
Watch a video below to learn more.
†Patient advocates are not healthcare professionals or medical experts. For medical questions, please contact your physician. Patient advocates are compensated by CSL Behring LLC. for their time and/or expenses.
This kit provides important resources to help you start and stay on Hizentra.Sign up for a kit
With Free Trial you can receive:
The Copay program helps eligible people afford their therapy by assisting with monthly out-of-pocket expenses for Hizentra. Most patients with commercial insurance pay $0 out-of-pocket.See if you are eligible
The Assurance program can help eligible patients continue to receive treatment even if they experience a lapse in third-party private health insurance.Learn how it works